Novavax, Inc. NVAX has announced a two-pronged variant strategy to provide protection against the new COVID-19 variant of concern (VOC), Omicron (B.1.1.529). Firstly, Novavax started evaluating …
https://finance.yahoo.com/news/novavax-nvax-starts-developing-omicron-202208101.html

